Clinical Trial Update: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

View source ↗

Summary

A completed observational study evaluated peginterferon alfa-2a (Pegasys) in patients with chronic hepatitis B, including both HBeAg-positive and HBeAg-negative…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Status: COMPLETED